Skip to main content
Caplight Logo









Iaterion, Inc.

Iaterion, Inc.

Private
Oakland, CaliforniaHealthcare & Life Scienceshttps://iaterion.com/

Last Round

VC Round

Feb 14, 2024

Total Funding Raised

$298,883

Company Overview

Iaterion, Inc. is a biotechnology company that develops targeted, selective nuclear receptor drugs as alternatives to menopausal hormone therapy for women's health and oncology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverywomen's healthoncologysmall-molecule therapeuticsnuclear receptor modulatorsnuclear receptor reprogrammingNRRPprecision medicinebiotech startupbreast cancer therapyhormone therapy alternativespreclinical developmentbiopharmafemtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Iaterion, Inc. Comparables

Compare Iaterion, Inc. with similar companies based on industry and business-model similarity.

Iaterion, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sermonix Pharmaceuticals
82%
Azure Biotech, Inc.
81%
Atossa Therapeutics Inc
74%

Iaterion, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 14, 2024
GrantSep 1, 2023

Key People

Founding team and executive leadership

Isaac Cohen

CEO

Executive Team

Iaterion, Inc. Investors

Notable investors and investment history

Iaterion, Inc. investors
InvestorRounds
National Institute on AgingGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 14, 2024

    Completed a VC Round funding round.

  • Sep 1, 2023

    $299K grant received from National Institute on Aging.

Iaterion, Inc. Filings

Explore SEC and related filing metadata, where available.

Iaterion, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Iaterion, Inc.'s valuation, stock price, and market status.

Is Iaterion, Inc. a public or private company?

Iaterion, Inc. is a private company.

What is the current stock price of Iaterion, Inc.?

Iaterion, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Iaterion, Inc. worth (valuation)?

Valuation information for Iaterion, Inc. is not publicly available.

Can I buy Iaterion, Inc. stock?

Iaterion, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Iaterion, Inc.'s last funding round?

Iaterion, Inc.'s most recent funding round was VC Round on February 14, 2024.

Who are the main investors in Iaterion, Inc.?

Key investors in Iaterion, Inc. include National Institute on Aging.

Will Iaterion, Inc. IPO soon?

No public IPO plans have been announced for Iaterion, Inc..

How can I track Iaterion, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Iaterion, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOakland, California
Employee Range3
Year Founded2014
Last FundingFeb 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?